Moolec Science SA Ordinary Shares (NASDAQ:MLEC) — Stock Price
Moolec Science SA Ordinary Shares (NASDAQ:MLEC) is currently trading at $7.01 USD, down 2.55% today. Over the past 52 weeks, shares have ranged between $0.22 and $17.10. This page tracks Moolec Science SA Ordinary Shares's live share price on the NASDAQ exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see market value of Moolec Science SA Ordinary Shares.
Moolec Science SA Ordinary Shares (MLEC) Stock Price Chart — Daily History & Trading Volume
The chart below tracks Moolec Science SA Ordinary Shares's daily closing share price and trading volume on the NASDAQ exchange over the past year, giving a clear view of recent price momentum and liquidity.
Moolec Science SA Ordinary Shares Income Statement — Revenue, Profit & Earnings by Year
Moolec Science SA Ordinary Shares's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Total Revenue | $333.61 Million | $5.63 Million | $905.05K | $0.00 |
| Cost of Revenue | $219.61 Million | $5.15 Million | $1.05 Million | $0.00 |
| Gross Profit | $114.01 Million | $472.58K | $-143.31K | $0.00 |
| Research & Development | $9.24 Million | $1.77 Million | $1.35 Million | $985.16K |
| SG&A | $88.83 Million | $6.54 Million | $47.42 Million | $2.52 Million |
| Total Operating Expenses | $124.48 Million | $9.52 Million | $6.51 Million | $3.65 Million |
| Operating Income | $-10.48 Million | $-9.04 Million | $-6.65 Million | $-1.72 Million |
| EBITDA | $-69.01 Million | $-6.16 Million | $-51.74 Million | $-3.65 Million |
| EBIT | $-91.27 Million | $-7.17 Million | $-51.86 Million | $-3.65 Million |
| Interest Expense | $41.81 Million | $1.17 Million | $160.03K | $2.13K |
| Income Before Tax | $-170.00 Million | $-8.34 Million | $-52.02 Million | $-93.81K |
| Income Tax Expense | $6.64 Million | $-1.05 Million | $-234.54K | $2.13K |
| Net Income | $-111.46 Million | $-7.31 Million | $-51.79 Million | $-4.53 Million |
Moolec Science SA Ordinary Shares Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes Moolec Science SA Ordinary Shares's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Assets | $204.71 Million | $34.79 Million | $24.05 Million | $5.69 Million | $138.59 Million |
| Total Current Assets | $31.19 Million | $13.75 Million | $5.33 Million | $1.08 Million | $581.70K |
| Cash & Equivalents | — | — | — | — | — |
| Short-term Investments | $8.25 Million | $14.67 Million | $306.03K | $0.00 | — |
| Net Receivables | $19.92 Million | $1.48 Million | $1.69 Million | $0.00 | $289.89K |
| Inventory | $2.24 Million | $6.28 Million | $465.75K | $0.00 | — |
| Property, Plant & Equipment | — | — | — | $8.92K | $10.62K |
| Goodwill | $0.00 | $262.53K | $251.44K | $0.00 | — |
| Total Liabilities | $287.58 Million | $27.97 Million | $13.95 Million | $4.09 Million | $4.51 Million |
| Total Current Liabilities | $236.05 Million | $8.15 Million | $12.60 Million | $4.09 Million | $861.85K |
| Long-term Debt | $19.61 Million | $11.70 Million | $99.05K | — | — |
| Net Debt | $246.11 Million | $9.29 Million | $117.62K | $-956.81K | $-212.60K |
| Total Stockholder Equity | $-65.97 Million | $6.82 Million | $10.11 Million | $1.60 Million | $134.08 Million |
| Retained Earnings | $-110.32 Million | $-65.94 Million | $-58.62 Million | $-6.83 Million | $-828.08K |
Moolec Science SA Ordinary Shares Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how Moolec Science SA Ordinary Shares generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Cash Flow | $-24.45 Million | $-9.33 Million | $-7.51 Million | $-915.08K | $-8.80K |
| Capital Expenditures | $5.65 Million | $158.28K | $179.19K | $0.00 | $0.00 |
| Free Cash Flow | $-30.10 Million | $-9.49 Million | $-7.69 Million | $-1.89 Million | $-8.80K |
| Investing Cash Flow | $-35.99 Million | $134.87K | $-2.34 Million | $-138.00 Million | — |
| Financing Cash Flow | $13.07 Million | $11.71 Million | $11.28 Million | $139.05 Million | $14.49K |
| Dividends Paid | $0.00 | $0.00 | $0.00 | $0.00 | — |
| Stock-Based Compensation | $4.39 Million | $2.05 Million | $43.80 Million | $838.58K | — |
| Depreciation | $22.25 Million | $1.01 Million | $122.02K | $1.70K | $1.70K |
| Change in Cash | $-52.23 Million | $2.86 Million | $1.45 Million | $131.02K | $5.69K |
Moolec Science SA Ordinary Shares Earnings History — EPS Actual vs. Analyst Estimates
Track Moolec Science SA Ordinary Shares's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| Mar 11, 2026 | 0.00 | -0.06 | +100.00% |
| Oct 27, 2025 | 0.00 | -0.70 | +100.00% |
| Apr 16, 2025 | -0.62 | -0.06 | -933.33% |
| Mar 12, 2025 | -0.06 | -0.06 | +0.00% |
| Oct 02, 2024 | -0.07 | -0.06 | -16.67% |
| Jun 30, 2024 | -0.60 | -0.60 | +0.00% |
| May 30, 2024 | -0.04 | -0.07 | +42.86% |
| Jan 22, 2024 | -0.04 | -0.04 | +0.00% |